Showing results (1-10 of 1,015) with videos related to
Sort By:
Pageof 102
Annales De Biologie Clinique|January 1, 1982
[The value of the measurement of intra-erythrocytic lithium in the bio-clinical surveillance of lithium therapy (author's transl)]J P Olie, C Gay, H Loo, et al.L'Encephale|December 16, 1998
[Subthreshold depressive disorders: description and importance for secondary prevention in psychiatry]C Castelnau, J P Olie, H LooBulletin De L'Academie Nationale De Medecine|November 1, 1993
[Treatment of heroin addicts by substitution with methadone. Importance, limits and experience in France]H Loo, X Laqueille, P Rémi, et al.L'Encephale|February 24, 2001
[Validation of the French translation and factorial structure of the Tiffany and Drobes Smoking Urge Questionnaire]O Guillin, M O Krebs, M C Bourdel, et al.Journal of Neural Transmission|January 1, 1986
Urinary 3-methoxy, 4-hydroxyphenylethylene glycol and therapeutic response to maprotiline and indalpine in major depressionH Loo, C Benkelfat, J M Vanelle, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2000
Evolution of plasma homovanillic acid (HVA) levels during treatment in schizo-affective disorderA Galinowski, C Castelnau, O Spreux-Varoquaux, et al.La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|April 18, 1981
[Psychopathology of depression (author's transl)]J P Olie, F PetitjeanL'Encephale|August 22, 2000
[Biological therapies of behavioral and psychological symptoms of dementia: update and prospects]T Gallarda, J P OlieConvulsive Therapy|September 1, 1994
Maintenance ECT in intractable manic-depressive disordersJ M Vanelle, H Loo, A Galinowski, et al.Psychopharmacology|January 1, 1986
Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depressionB Scatton, H Loo, T Dennis, et al.Pageof 102